ORKA Collar Strategy
ORKA (Oruka Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.
ORKA (Oruka Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.39B, a beta of -0.30 versus the broader market, a 52-week range of 10.97-91.12, average daily share volume of 1.7M, a public-listing history dating back to 1997, approximately 28 full-time employees. These structural characteristics shape how ORKA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.30 indicates ORKA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ORKA pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a collar on ORKA?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current ORKA snapshot
As of June 30, 2026, spot at $94.85, ATM IV 106.60%, IV rank 15.48%, expected move 30.56%. The collar on ORKA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on ORKA specifically: IV regime affects collar pricing on both sides; compressed ORKA IV at 106.60% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 30.56% (roughly $28.99 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORKA expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORKA should anchor to the underlying notional of $94.85 per share and to the trader's directional view on ORKA stock.
ORKA collar setup
The ORKA collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORKA near $94.85, the first option leg uses a $100.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORKA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORKA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $94.85 | long |
| Sell 1 | Call | $100.00 | $6.80 |
| Buy 1 | Put | $90.00 | $5.50 |
ORKA collar risk and reward
- Net Premium / Debit
- -$9,355.00
- Max Profit (per contract)
- $645.00
- Max Loss (per contract)
- -$355.00
- Breakeven(s)
- $93.55
- Risk / Reward Ratio
- 1.817
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
ORKA collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on ORKA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$355.00 |
| $20.98 | -77.9% | -$355.00 |
| $41.95 | -55.8% | -$355.00 |
| $62.92 | -33.7% | -$355.00 |
| $83.89 | -11.6% | -$355.00 |
| $104.86 | +10.6% | +$645.00 |
| $125.83 | +32.7% | +$645.00 |
| $146.81 | +54.8% | +$645.00 |
| $167.78 | +76.9% | +$645.00 |
| $188.75 | +99.0% | +$645.00 |
When traders use collar on ORKA
Collars on ORKA hedge an existing long ORKA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
ORKA thesis for this collar
The market-implied 1-standard-deviation range for ORKA extends from approximately $65.86 on the downside to $123.84 on the upside. A ORKA collar hedges an existing long ORKA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current ORKA IV rank near 15.48% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORKA at 106.60%. As a Healthcare name, ORKA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORKA-specific events.
ORKA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORKA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORKA alongside the broader basket even when ORKA-specific fundamentals are unchanged. Always rebuild the position from current ORKA chain quotes before placing a trade.
Frequently asked questions
- What is a collar on ORKA?
- A collar on ORKA is the collar strategy applied to ORKA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With ORKA stock trading near $94.85, the strikes shown on this page are snapped to the nearest listed ORKA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ORKA collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the ORKA collar priced from the end-of-day chain at a 30-day expiry (ATM IV 106.60%), the computed maximum profit is $645.00 per contract and the computed maximum loss is -$355.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORKA collar?
- The breakeven for the ORKA collar priced on this page is roughly $93.55 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ORKA market-implied 1-standard-deviation expected move is approximately 30.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on ORKA?
- Collars on ORKA hedge an existing long ORKA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current ORKA implied volatility affect this collar?
- ORKA ATM IV is at 106.60% with IV rank near 15.48%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.